Business Context and Reporting Period
This Form 6-K filing by Enlivex Therapeutics Ltd. (Enlivex) covers the month of October 2022. The report announces the scheduling of the Company's 2022 Annual General Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a corporate governance notice rather than a financial results report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing.
Guidance, Outlook, and Corporate Actions
- Annual Meeting: Scheduled for Thursday, November 17, 2022, at 7:00 p.m. Israel time.
- Location: Company offices at 14 Einstein Street, Nes Ziona, Israel 7403618.
- Proxy Materials: The proxy statement, proxy card, and notice of internet availability are attached as Exhibits 99.1, 99.2, and 99.3.
- Corporate Governance: Information regarding board practices and executive compensation is incorporated by reference into the Company's registration statements on Forms S-8, F-3, and F-3MEF.
Investor Verification Checklist
- Verify the date and time of the Annual General Meeting (November 17, 2022).
- Review the attached proxy statement (Exhibit 99.1) for specific agenda items and voting proposals.
- Confirm the location of the meeting in Nes Ziona, Israel.
- Check the referenced registration statements (File Nos. 333-256799, 333-232413, 333-232009, 333-252926, 333-264561) for detailed governance and compensation data.